Clinical trial
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
NCT03368144 is registered in ClinicalTrials.gov with ID3 Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
- Lead sponsor
- ID3 Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 21, 2017
- Completion date
- October 7, 2021
- Enrollment
- 25 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.